(Nanowerk News) The provision of blood for patients who require repeated blood transfusions, as well as for individuals with rare blood types, presents an enormous challenge to transfusion services ...
Grifols sCD38 is the industry's first-ever soluble recombinant protein designed to overcome the interference that the cancer therapy daratumumab has on critical blood-transfusion tests The solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback